Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines.
about
Molecular cloning and characterization of a transcription regulator with homology to GC-binding factorInhibition of tumor growth by a monoclonal antibody reactive with an oncogene-encoded tumor antigenSoluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical RelevanceThe role of tyrosine kinase Etk/Bmx in EGF-induced apoptosis of MDA-MB-468 breast cancer cellsMeasurement of cetuximab and panitumumab-unbound serum EGFR extracellular domain using an assay based on slow off-rate modified aptamer (SOMAmer) reagentsEGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK.Cloning and characterization of the promoter region of the rat epidermal growth factor receptor gene and its transcriptional regulation by nerve growth factor in PC12 cells.Molecular organization of the human Raf-1 promoter region.Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway.A transcription factor active on the epidermal growth factor receptor gene.Amplification of the proto-neu oncogene facilitates oncogenic activation by a single point mutation.Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomasEpidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.Elevated epidermal growth factor receptor gene copy number and expression in a squamous carcinoma cell line.Characterization of the promoter region of the human c-erbB-2 protooncogeneActivity of a recombinant fusion protein between transforming growth factor type alpha and Pseudomonas toxinChromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells.Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients.Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs.A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma.The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.Oncogenes in human testicular cancer: DNA and RNA studiesAn enhanced and sensitive autocrine stimulation by transforming growth factor-alpha is acquired in the brain metastatic variant of a human non-small-cell lung cancer cell lineDemonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells.Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck.Epidermal growth factor receptor gene-amplified MDA-468 breast cancer cell line and its nonamplified variants.Modulation of epidermal growth factor receptor proto-oncogene transcription by a promoter site sensitive to S1 nucleaseStructure and localization of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells.Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patientsMutations in the polybasic juxtamembrane sequence of both plasma membrane- and endoplasmic reticulum-localized epidermal growth factor receptors confer ligand-independent cell transformation.Characterization and sequence of the promoter region of the human epidermal growth factor receptor gene.Epidermal growth factor regulates the expression of its own receptor.Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors.The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling.Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery.Liquid Biopsies in the Screening of Oncogenic Mutations in NSCLC and its Application in Targeted Therapy.Growth factors in cancer and their relationship to oncogenes.Mechanisms by which genes encoding growth factors and growth factor receptors contribute to malignant transformation.
P2860
Q24323630-93F74BFD-CBDB-4BC0-A292-C8E504483C75Q24628627-050E4C24-37B6-4CD7-98FE-B8C6D61F4D38Q26750970-9475147F-4D2C-4F85-8F3D-FE25026089D5Q28191639-C85D5727-3799-4E2C-BAA8-E7FA2979937CQ28535487-7449BDB6-4870-4190-ACE1-B07C7CE4796FQ30424563-F1450C25-E5B8-469F-BB29-21C2DC1801BDQ30843762-97EE3715-8AA0-41FA-96EE-4AA08070521DQ33255737-36A89E06-C1B1-4B11-89E3-6E5FF5FDD84DQ33508697-C6989EC8-A07B-4BF6-ACF8-78D438C1BE3DQ33631334-A4D2B137-AC37-4BC2-A8EF-3A6779B79FD5Q33849412-485896CE-39C8-4094-9A03-B84FC4F2CB0EQ33881165-C2070E27-8E9B-4DD5-A1FF-0308F11AE195Q34263559-B7F10546-A2DC-4DE3-AB65-AE19FFBBC8BDQ34350623-671D12A8-D789-4450-97D2-0DF9B5137B91Q34538847-7529855C-4D36-4F49-8C82-A9FF916B2C83Q34633898-FA284AA6-254C-4B15-9A10-863DAC74CE4BQ34635622-DDD313B8-B5BB-437C-B3D0-0A2A4A0AD373Q35017851-3F5A0C28-B6BF-42C1-80FF-A1498F5FF57AQ35034638-BF73ACA3-4423-416C-A3FD-56AA577996C3Q35565473-39289662-BD2A-4BA9-8FE3-FF252980D521Q35660849-5EDAF232-7FD7-4D57-A46E-7757A7081CF3Q35700713-7C354AED-D64C-4939-86A2-ECDE30BF9F7DQ35841701-B22C98E3-80FD-4A24-9D36-C58FECE23FDDQ35984739-FF832E6D-6BC6-447A-9AEB-5F32A8370E85Q36141268-28A77541-5154-4156-A243-3915D5D5A02CQ36205683-4D4032B9-8947-48A4-9F76-84A58746E08FQ36467548-2ECE3197-0F85-4198-AC52-D71141A34995Q36833392-EED89017-466F-48EA-B7EA-E9A07B75CA04Q36846716-CF1B1856-C7A1-4A1A-86B1-35B141FCCF79Q36903694-D913939F-7D24-4E17-B7B0-51700FDAD6D2Q37135262-A68699E6-77DF-41B7-9F67-87593643DC56Q37349031-E3A72CBC-6C4C-4F8B-AF5E-32FC4CF14A6DQ37524558-8D3DC9B2-8C81-4B58-BB43-A826A167E510Q37538959-D1D2FD7E-EF10-4C7B-A000-A3B08C9FC230Q37685971-9F0E14E4-2ECF-41FE-BADA-63B36B23DE21Q38349130-9C5B65E1-F4D9-4638-B5AD-C85CE0689201Q38852900-3FB02412-0AAC-43AC-BAEB-2ADC5290A707Q38859701-E163E3D0-5227-461D-B0C9-4805067788A1Q39500167-394DEEF4-3D33-4C2B-99DE-6B9FB7BFA73FQ39573056-6AE85BE7-CD8B-4745-B15B-31B9C2BA888E
P2860
Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1984
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of epidermal ...... t and normal human cell lines.
@en
Characterization of epidermal ...... t and normal human cell lines.
@nl
type
label
Characterization of epidermal ...... t and normal human cell lines.
@en
Characterization of epidermal ...... t and normal human cell lines.
@nl
prefLabel
Characterization of epidermal ...... t and normal human cell lines.
@en
Characterization of epidermal ...... t and normal human cell lines.
@nl
P2093
P2860
P356
P1476
Characterization of epidermal ...... t and normal human cell lines.
@en
P2093
P2860
P304
P356
10.1073/PNAS.81.23.7308
P407
P577
1984-12-01T00:00:00Z